Australia markets open in 9 hours 8 minutes

TOT BIOPHARM International Company Limited (1875.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
2.200-0.030 (-1.35%)
At close: 03:54PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-37,757
-37,757
-49,916
-261,216
-288,498
-
Depreciation & amortisation
27,351
43,028
38,039
34,237
32,082
-
Stock-based compensation
23,557
10,643
16,111
5,296
15,832
-
Change in working capital
-32,495
11,729
40,546
49,224
-19,790
-
Inventory
-12,145
-31,188
-65,263
-21,444
7,136
-
Other working capital
-146,769
-146,769
-180,194
-290,450
-285,297
-
Other non-cash items
494
2,201
4,337
1,499
-174
-
Net cash provided by operating activities
56,431
56,431
59,929
-175,137
-263,116
-
Cash flows from investing activities
Investments in property, plant and equipment
-203,200
-203,200
-240,123
-115,313
-22,181
-
Acquisitions, net
-5,600
-5,600
-5,150
-1,500
0
-
Purchases of investments
-280,000
-280,000
-255,000
0
-365,570
-
Sales/maturities of investments
321,215
321,215
215,634
8,402
399,919
-
Net cash used for investing activities
-164,105
-164,105
-282,764
-108,393
12,526
-
Net change in cash
-69,449
-69,449
258,405
-71,448
-312,297
-
Cash at beginning of period
417,769
417,769
152,805
225,533
539,180
-
Cash at end of period
351,600
351,600
417,769
152,805
225,533
-
Free cash flow
Operating cash flow
56,431
56,431
59,929
-175,137
-263,116
-
Capital expenditure
-203,200
-203,200
-240,123
-115,313
-22,181
-
Free cash flow
-146,769
-146,769
-180,194
-290,450
-285,297
-